author-photo

Eitan Rubin

Ben-Gurion University of the Negev

61

Papers

1574

Citations

Citation Trend

Filter By

Papers (40) Sort By

Journal Conference Others

Transcriptomics in Tumor and Normal Tissues and Precision Oncology Algorithms Identify Early-Stage NSCLC Patients with High Risk of Post-Surgery Recurrence Who May Benefit from Adjuvant Therapies

2021 Social Science Research Network
Show All
- Source
- Cite
- Save
Citations (0)
Synthetic lethality-mediated precision oncology via the tumor transcriptome.

2021 Cell
Show All
- Source
- Cite
- Save
Citations (3)
Whole exome precision oncology targeting synthetic lethal vulnerabilities across the tumor transcriptome

2020 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Identification of tumor antigens in the HLA peptidome of patient-derived xenograft tumors in mouse.

2020 Molecular & Cellular Proteomics
Show All
- Source
- Cite
- Save
Citations (3)
Gray whale transcriptome reveals longevity adaptations associated with DNA repair and ubiquitination.

2020 Aging Cell
Show All
- Source
- Cite
- Save
Citations (11)
1574PSurvival prolongation by rationale innovative genomics (SPRING): An international WIN consortium phase I study exploring safety and efficacy of avelumab, palbociclib, and axitinib in advanced non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
BORIS/CTCFL promotes a switch from a proliferative towards an invasive phenotype in melanoma cell lines

2019 bioRxiv
Show All
- Source
- Cite
- Save
Citations (0)
Abstract CT223: Survival Prolongation by Rationale INnovative Genomics (SPRING): An international WIN Consortium Phase I/II proof-of-concept study to explore the safety and efficacy of a tri-therapy approach using avelumab, palbociclib and axitinib in advanced/metastatic non-small cell lung cancer (NSCLC) with integrated genomic and transcriptomic correlates

2019 Clinical Trials
Show All
- Source
- Cite
- Save
Citations (0)
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial

2019 Nature Medicine
Show All
- Source
- Cite
- Save
Citations (185)
PCM-SABRE: a platform for benchmarking and comparing outcome prediction methods in precision cancer medicine

2017 BMC Bioinformatics
- Noah Eyal-Altman
- Eitan Rubin
Show All
- Source
- Cite
- Save
Citations (8)